{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:37:42Z","timestamp":1784219862273,"version":"3.55.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,15]]},"DOI":"10.1093\/infdis\/jix263","type":"journal-article","created":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T07:07:51Z","timestamp":1495782471000},"page":"198-202","source":"Crossref","is-referenced-by-count":48,"title":["Valganciclovir for the Suppression of Epstein-Barr Virus Replication"],"prefix":"10.1093","volume":"216","author":[{"given":"Jessica E","family":"Yager","sequence":"first","affiliation":[{"name":"Department of Medicine, State University of New York Downstate Medical Center, Brooklyn; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia S","family":"Magaret","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and Departments of"},{"name":"Laboratory Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R","family":"Kuntz","sequence":"additional","affiliation":[{"name":"Laboratory Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Selke","sequence":"additional","affiliation":[{"name":"Laboratory Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meei-Li","family":"Huang","sequence":"additional","affiliation":[{"name":"Laboratory Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Corey","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and Departments of"},{"name":"Laboratory Medicine,"},{"name":"Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Casper","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and Departments of"},{"name":"Medicine, and"},{"name":"Epidemiology, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wald","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and Departments of"},{"name":"Laboratory Medicine,"},{"name":"Medicine, and"},{"name":"Epidemiology, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,30]]},"reference":[{"key":"key\n\t\t\t\t20180306115505_CIT0001","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJM197606172942501","article-title":"Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx","volume":"294","author":"Niederman","year":"1976","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180306115505_CIT0002","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein-Barr virus and the origins of associated lymphomas","volume":"350","author":"Thorley-Lawson","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180306115505_CIT0003","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcv.2007.02.002","article-title":"A virologic pilot study of valacyclovir in infectious mononucleosis","volume":"39","author":"Balfour","year":"2007","journal-title":"J Clin Virol"},{"key":"key\n\t\t\t\t20180306115505_CIT0004","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1080\/1042819031000103926","article-title":"Effective anti-viral therapy for hemophagocytic syndrome associated with B-cell lymphoma","volume":"44","author":"Gomyo","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20180306115505_CIT0005","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/infdis\/jir060","article-title":"Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy","volume":"203","author":"Hunt","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306115505_CIT0006","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jcv.2014.01.005","article-title":"Valganciclovir suppressed Epstein Barr virus reactivation during immunosuppression with alemtuzumab","volume":"59","author":"Gill","year":"2014","journal-title":"J Clin Virol"},{"key":"key\n\t\t\t\t20180306115505_CIT0007","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/588820","article-title":"Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial","volume":"198","author":"Casper","year":"2008","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306115505_CIT0008","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/00365549950164409","article-title":"Acyclovir for treatment of infectious mononucleosis: a meta-analysis","volume":"31","author":"Torre","year":"1999","journal-title":"Scand J Infect Dis"},{"key":"key\n\t\t\t\t20180306115505_CIT0009","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2009.25.4961","article-title":"Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era","volume":"28","author":"Evens","year":"2010","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180306115505_CIT0010","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/00007890-199709270-00010","article-title":"Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy","volume":"64","author":"Darenkov","year":"1997","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20180306115505_CIT0011","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1111\/j.1600-6143.2005.01115.x","article-title":"Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients","volume":"5","author":"Funch","year":"2005","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20180306115505_CIT0012","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/jmv.21214","article-title":"Oral mucosal reactivation rates of herpesviruses among HIV-1 seropositive persons","volume":"80","author":"Griffin","year":"2008","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20180306115505_CIT0013","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1128\/JVI.02638-15","article-title":"Replication of human herpesviruses is associated with higher HIV DNA levels during antiretroviral therapy started at early phases of HIV infection","volume":"90","author":"Gianella","year":"2016","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180306115505_CIT0014","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1128\/AAC.38.9.2175","article-title":"Substrate specificity of Epstein-Barr virus thymidine kinase","volume":"38","author":"Tung","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180306115505_CIT0015","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/jmv.22194","article-title":"Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men","volume":"83","author":"Cattamanchi","year":"2011","journal-title":"J Med Virol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/2\/198\/24264062\/jix263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T11:55:15Z","timestamp":1520337315000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/216\/2\/198\/3858428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,30]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,5,30]]},"published-print":{"date-parts":[[2017,7,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix263","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7,15]]},"published":{"date-parts":[[2017,5,30]]}}}